摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(5-benzyl-hexahydro-pyrrolo[3,4-c]pyrrol-2-yl)-(4,6-dimethyl-pyrimidin-5-yl)-methanone | 1014702-81-8

中文名称
——
中文别名
——
英文名称
(5-benzyl-hexahydro-pyrrolo[3,4-c]pyrrol-2-yl)-(4,6-dimethyl-pyrimidin-5-yl)-methanone
英文别名
(2-benzyl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl)-(4,6-dimethylpyrimidin-5-yl)methanone
(5-benzyl-hexahydro-pyrrolo[3,4-c]pyrrol-2-yl)-(4,6-dimethyl-pyrimidin-5-yl)-methanone化学式
CAS
1014702-81-8
化学式
C20H24N4O
mdl
——
分子量
336.437
InChiKey
KHHUEOMIJHYHBE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.1
  • 重原子数:
    25
  • 可旋转键数:
    3
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.45
  • 拓扑面积:
    49.3
  • 氢给体数:
    0
  • 氢受体数:
    4

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2

反应信息

点击查看最新优质反应信息

文献信息

  • Heterocyclic antiviral compounds
    申请人:Lee Kyung Eun
    公开号:US20060014767A1
    公开(公告)日:2006-01-19
    Chemokine receptor antagonists, in particular, 3,7-diazabicyclo[3.3.0]octane compounds according to formula (I) are antagonists of chemokine CCR5 receptors which are useful for treating or preventing an human immunodeficiency virus (HIV) infection, or treating AIDS or ARC. The invention further provides methods for treating diseases that are allieviated with CCR5 antagonists. The invention includes pharmaceutical compositions and methods of using the compounds for the treatment of these diseases. The invention further includes processes for the preparation of compounds according to formula I.
    化学因子受体拮抗剂,尤其是按照公式(I)制备的3,7-二氮杂双环[3.3.0]辛烷类化合物是化学因子CCR5受体的拮抗剂,可用于治疗或预防人类免疫缺陷病毒(HIV)感染,或治疗艾滋病或ARC。发明还提供了用于缓解与CCR5拮抗剂相关的疾病的治疗方法。该发明包括制备公式I化合物的药物组合物和使用这些化合物治疗这些疾病的方法。该发明还包括制备公式I化合物的过程。
  • Heterocylic antiviral compounds
    申请人:Lemoine Remy
    公开号:US20080103125A1
    公开(公告)日:2008-05-01
    Chemokine receptor antagonists, in particular, 3,7-diazabicyclo[3.3.0]octane compounds according to formula (I) wherein R 1 -R 3 and Ar are as defined herein are antagonists of chemokine CCR 5 receptors which are useful for treating or preventing an human immunodeficiency virus (HIV) infection, or treating AIDS or ARC. The invention further provides methods for treating diseases that are alleviated with CCR 5 antagonists. The invention includes pharmaceutical compositions and methods of using the compounds for the treatment of these diseases. The invention further includes processes for the preparation of compounds according to formula I.
    化学因子受体拮抗剂,特别是根据公式(I)其中R1-R3和Ar的定义为所定义的3,7-二氮杂双环[3.3.0]辛化合物是化学因子CCR5受体的拮抗剂,可用于治疗或预防人类免疫缺陷病毒(HIV)感染,或治疗艾滋病或ARC。该发明进一步提供了用于治疗通过CCR5拮抗剂缓解的疾病的方法。该发明包括制备公式I化合物的制备方法和用于治疗这些疾病的制药组合物和方法。
  • Octahydro-pyrrolo[3,4-c]pyrrole CCR5 receptor antagonists
    申请人:Roche Palo Alto LLC
    公开号:US07625905B2
    公开(公告)日:2009-12-01
    Chemokine receptor antagonists, in particular, 3,7-diazabicyclo[3.3.0]octane compounds according to formula (I) wherein R1-R3 and Ar are as defined herein are antagonists of chemokine CCR5 receptors which are useful for treating or preventing an human immunodeficiency virus (HIV) infection, or treating AIDS or ARC. The invention further provides methods for treating diseases that are alleviated with CCR5 antagonists. The invention includes pharmaceutical compositions and methods of using the compounds for the treatment of these diseases. The invention further includes processes for the preparation of compounds according to formula I.
    化学因子受体拮抗剂,特别是根据公式(I)中定义的R1-R3和Ar的3,7-二氮杂双环[3.3.0]辛化合物,是化学因子CCR5受体的拮抗剂,用于治疗或预防人类免疫缺陷病毒(HIV)感染,或治疗艾滋病或ARC。本发明还提供了治疗使用CCR5拮抗剂缓解的疾病的方法。本发明包括制备公式I中化合物的药物组合物和使用这些化合物治疗这些疾病的方法。本发明还包括制备公式I中化合物的方法。
  • [EN] OCTAHYDRO-PYRROLO[3,4-C] DERIVATIVES AND THEIR USE AS ANTIVIRAL COMPOUNDS<br/>[FR] COMPOSES ANTIVIRAUX HETEROCYCLIQUES
    申请人:HOFFMANN LA ROCHE
    公开号:WO2005121145A3
    公开(公告)日:2006-03-02
  • OCTAHYDROPYRROLO[3,4-C]PYRROLE DERIVATIVES AN THEIR USE AS ANTIVIRAL AGENTS
    申请人:F.HOFFMANN-LA ROCHE AG
    公开号:EP1761542A2
    公开(公告)日:2007-03-14
查看更多